You are here
Cordlife's 'belle of the ball' in bid for China Cord Blood
A TAKEOUT offer for a major China cord blood firm listed on the New York Stock Exchange is firing up interest in its substantial shareholder Singapore-listed Cordlife Group with expectations that it too may be a target in the bid to control China Cord Blood Corp (CCBC).
- CALL +65 6388 3838
- EMAIL firstname.lastname@example.org